The claims that trans identity spreads socially like a virus, and that gender-affirming care amounts to sterilising children, are not research findings. They are coordinated rhetorical moves, designed to make ordinary healthcare sound like harm, and to make trans young people sound like victims of a trend rather than people who know who they are. Both claims are contradicted by decades of evidence and rejected by every major medical body in the world. Here is what is actually going on.
Where did "social contagion" come from?
The phrase "rapid-onset gender dysphoria" was coined in a 2018 paper by Lisa Littman. It proposed, based on parental surveys from advocacy websites hostile to transition, that some adolescents were developing gender dysphoria not from internal experience but from peer influence and social media exposure. It was heavily criticised from the moment it appeared: its methodology was not capable of supporting the conclusions drawn, it did not survey the young people themselves, and it sourced its sample from forums where parents were already primed to see their children's gender identity as a mistake.
WPATH, the Endocrine Society, the American Academy of Pediatrics, and dozens of professional bodies have not adopted this framework. The American Academy of Child and Adolescent Psychiatry explicitly reaffirmed its support for evidence-based gender-affirming care in 2025, directly in response to the political pressure that was trying to use framing like this to restrict treatment.
That does not stop the phrase circulating. It has become a standard piece of anti-trans rhetoric precisely because it sounds scientific while doing the work of a political claim: if gender identity is socially contagious, then trans young people are not really trans, and helping them is enabling harm rather than preventing it.
What the research actually shows
Trans people have existed in every documented culture and across all of recorded history. The idea that trans identity is new, or that it spreads like a pathogen, collapses the moment you look at the broader picture: what has changed is not the number of trans people, but the visibility of trans people, the availability of language to describe experience, and the reduced social cost of naming yourself truthfully.
When young people come out in clusters, the explanation that fits the evidence is not contagion. It is that having a word for your experience, and knowing someone else who shares it, makes it safer to say the thing you already knew. This is not how viruses work. It is how safety works.
The research literature on gender-affirming care, drawn from decades of clinical practice across multiple countries, consistently shows that young people who access care have better mental health outcomes: lower rates of depression, anxiety, and suicidality. The harms the anti-trans framing predicts do not materialise in the data. The harms of withholding care do.
What does "sterilising children" actually mean in this context?
Puberty blockers do not sterilise anyone. They pause puberty. They are fully reversible in the sense that puberty resumes when the medication stops. They have been used for decades in the treatment of precocious puberty in children who are not trans, and no serious clinical voice describes that use as sterilisation.
The claim that puberty blockers sterilise children is not a clinical concern that crept into political debate. It is a political claim that borrows clinical-sounding language. The goal is to make a standard, internationally supported medical intervention sound like mutilation, because if it sounds like mutilation it becomes easier to ban.
Cross-sex hormones, taken over a long period, can affect fertility. That is a real clinical consideration, and good gender-affirming care includes honest, age-appropriate conversation about it. Fertility preservation is available and is discussed as part of the process. But acknowledging a genuine consideration is very different from describing care as sterilisation, which implies something done to a child without consent, against their interests, for no good reason.
Gender-affirming surgery on children under 18 is extremely rare, occurs only in specific circumstances, and is nothing like the wholesale mutilation the rhetoric implies. The clinical reality does not resemble the description being circulated.
Why is this happening now, and who is coordinating it?
The social contagion and sterilisation framing did not emerge independently from multiple concerned citizens all arriving at the same conclusion. It emerged from a coordinated network of organisations whose stated purpose is to limit or eliminate trans healthcare, particularly for young people. Groups like SEGM (the Society for Evidence-based Gender Medicine) have produced material that appears peer-reviewed but functions to present political opposition in a scientific-sounding form. The Cass Review in the UK relied heavily on SEGM-linked work, and has since been internationally discredited and widely critiqued by gender medicine specialists.
The pile-on dynamic works like this: a politically motivated claim enters the media as a research finding, outlets repeat it as if it were settled science, politicians cite the coverage as justification for legislation, and by the time the original claim has been dismantled, the law has already been passed. This is not a conspiracy theory. It is a documented pattern, and recognising it does not require any particular political view. It requires reading the sources.
In the UK, the sale of puberty blockers to trans young people on private prescription has been banned. In parts of the United States, gender-affirming care for minors has been restricted or criminalised. These policy changes were made possible by the social contagion and sterilisation framing doing its work in public discourse before the clinical refutations had time to land.
What should you say when you hear these claims?
The first thing worth knowing is that you do not need to win a scientific debate to help someone. The framing is designed to be overwhelming: it arrives with acronyms, study citations, and an air of reluctant concern for the children. It is designed to make the person defending trans young people look as if they are the one ignoring evidence.
The counter is simple. Ask where the evidence comes from. Ask whether the major clinical bodies have adopted the framework. Ask what the actual clinical outcomes data shows. And ask who funded or sourced the original work. Those questions, asked calmly, tend to collapse the argument fairly quickly, because the foundations of the social contagion and sterilisation framing do not survive scrutiny.
When someone raises these claims in good faith, because they have read a headline and are genuinely worried, the conversation is different. Good faith deserves a patient answer. What I find, in those conversations, is that most people are not anti-trans. They have been told something frightening about children being harmed, and they want reassurance that the children are safe. The answer is: yes, trans children are safer when they are believed, supported, and given access to care. The evidence for that is not contested in serious clinical circles. What is contested is whether trans children deserve to be treated as well as other children.
The Cass Review and the evidence problem
You will hear the Cass Review cited as the authoritative British evidence base for restricting care. It is not. The review relied on a methodology for evaluating evidence that no other area of paediatric medicine applies, effectively setting a standard for gender-affirming care that no existing treatment could meet. It drew heavily on work from SEGM-linked researchers. It has been subjected to detailed published rebuttals by gender medicine specialists. Its conclusions led to the UK ban on puberty blockers and to restrictions on NHS care that have caused documented harm to trans young people who were already waiting years for treatment.
Internationally, the Cass Review has not been adopted as a model. The clinical communities that know this field best have not changed their guidelines in response to it. That is not because they are ignoring it. It is because they have read it critically and found it wanting.
What trans young people actually need
Trans young people need to be believed. They need adults around them who do not treat their identity as a symptom, a phase, or an import from social media. They need access to care that has been shown, across decades of practice, to improve their wellbeing. And they need the adults around them to be able to hold firm when the noise gets loud, because the noise right now is very loud indeed.
The social contagion framing and the sterilisation framing are not primarily arguments about medicine. They are arguments about whether trans young people are real. Every time I hear them, what I hear underneath is the question: are these children actually who they say they are? And the answer, from the evidence and from everything I have learned listening to trans people and families over many years, is yes. They are.
If there is a topic that you would like me to cover, just let Sammy know.
Dr Helen Webberley is a Gender Specialist and advocate, and the founder of GenderGP. She writes about gender diversity, trans healthcare, and the fight for equality.